Prediction: Nvidia Stock Is a Buy Before May 20

Nvidia expects Q1 fiscal 2027 revenue of $78 billion at the midpoint, implying about 77% year-over-year growth, with investors now focused on Q2 guidance and China demand recovery. The company is set to resume H200 chip sales in China and still holds an estimated 55% share of that market, while management has projected $1 trillion in sales from Vera Rubin and Blackwell through 2027. The article frames the stock as attractive on the dip despite recent geopolitical and sentiment-driven weakness.

Analysis

The market is still treating NVDA like a mature mega-cap momentum name, but the setup is more like an underappreciated option on a China normalization + second-gen product cycle. If management sounds confident on Q2 and reframes the rest of FY27 as unconstrained supply absorption rather than demand saturation, the stock can rerate because current positioning appears to be anchored to skepticism, not fundamentals. The asymmetry is that the next leg is less about beating a quarter and more about reopening a revenue stream that can mechanically lift estimates for multiple periods.

The second-order winner is the AI infrastructure stack that depends on NVDA staying the reference architecture: foundry, advanced packaging, HBM memory, optics, and networking names should all benefit if the company reiterates that demand is still ahead of supply. The risk is that any China commentary comes with caveats on licensing, shipment timing, or mix, which would compress near-dated expectations even if headline demand remains intact. That creates a window where the stock can sell off on narrative disappointment despite positive underlying order trends.

The contrarian miss is that the market may be underpricing the duration of enterprise and sovereign AI spending, but overpricing the immediacy of monetization from China. In other words, the real upside is likely spread across the next 2-4 quarters, not just on the print date. If guidance implies Vera Rubin ramps into an already-tight supply environment, the shares can continue to grind higher even without a blowout quarter, because estimate revisions will matter more than the one-night reaction.

Key Decisions for Investors

• Buy NVDA on any pre-earnings weakness, using a 4-8 week horizon into and after the May 20 release; target upside is a multiple-expansion move if Q2 guidance implies China re-entry and no demand air pocket, with downside limited by secular backlog support.
• Use a bullish call spread on NVDA into earnings (e.g. 1-3 month tenor) to express upside from a guidance beat while capping premium at risk; best risk/reward if implied vol remains elevated but not extreme.
• Long a basket of NVDA supply-chain beneficiaries vs. short a broad semiconductor ETF over 1-3 months if management confirms supply remains tight; the basket should outperform on incremental capex and packaging spend even if the market stays selective on pure chip beta.
• Avoid fading NVDA on the headline quarter alone; wait for any post-earnings selloff tied to China execution concerns, then reassess after guidance, since the more durable catalyst is FY27 estimate revision, not a single-quarter beat.
• If the stock gaps up strongly on May 20, rotate part of the gain into longer-dated exposure rather than taking full profits immediately; the better trade may be owning the next 2-3 quarters of forecast upgrades rather than chasing the print.